002720 — Kukje Pharma Co Cashflow Statement
0.000.00%
- KR₩101bn
- KR₩122bn
- KR₩135bn
Annual cashflow statement for Kukje Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4,762 | 2,195 | -1,556 | 3,543 | -8,415 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 8,490 | 13,188 | 4,235 | 2,964 | 5,705 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,375 | -13,909 | 2,499 | -4,491 | 2,081 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,604 | 5,100 | 9,597 | 6,504 | 3,575 |
Capital Expenditures | -5,887 | -11,600 | -1,961 | -1,277 | -1,046 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 760 | 2,619 | -1,421 | -70.1 | -129 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5,127 | -8,981 | -3,382 | -1,347 | -1,175 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5,334 | 622 | -2,434 | -7,474 | 2,610 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3,789 | -3,435 | 3,853 | -2,327 | 5,051 |